Viroclinics Xplore

Viroclinics Xplore is the specialized preclinical division of Viroclinics Biosciences, a leading virology contract research organization (CRO) headquartered in the Netherlands. The company provides a comprehensive range of early-stage drug discovery and preclinical development services, with a primary focus on respiratory viruses such as influenza, RSV, and SARS-CoV-2. Their expertise includes virus neutralization assays, molecular biology, and specialized animal models for testing vaccines and antiviral candidates. Following its acquisition by Cerba Research, Viroclinics Xplore operates as part of a global network providing end-to-end clinical trial services for the biopharmaceutical industry.